Company news
Nuwellis, Inc. news in 2023
Nuwellis, Inc.'s news releases, calls and decks from 2023, newest first.
Nuwellis, Inc. Announces Third Quarter 2023 Financial Results
November 6, 2023
Nuwellis Announces Board of Directors Transition
October 31, 2023
Nuwellis, Inc. To Announce Third Quarter 2023 Financial Results on November 7, 2023
October 17, 2023
Nuwellis Announces Pricing of $2.25 Million Public Offering of Series J Convertible Redeemable Preferred Stock and Warrants
October 12, 2023
Nuwellis Provides Regulatory Update on SeaStar Medical’s Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device Exemption
October 9, 2023
Nuwellis, Inc. Announces Second Quarter 2023 Financial Results
August 7, 2023
Nuwellis Announces Plan for CFO Transition
August 7, 2023
Nuwellis, Inc. To Announce Second Quarter 2023 Financial Results on August 8, 2023
July 17, 2023
Nuwellis Inc. Announces Pilot Agreement With DaVita Inc.
June 19, 2023
Nuwellis Announces the Appointment of Mike McCormick to its Board of Directors
June 4, 2023
Nuwellis, Inc. Announces First Quarter 2023 Financial Results
May 8, 2023
Nuwellis, Inc. To Announce First Quarter 2023 Financial Results on May 9, 2023
April 17, 2023
Nuwellis Announces Peer-Reviewed Publication of Clinical Trials Analysis Advocating the Use of Ultrafiltration for Heart Failure Patients Resistant to Diuretics
March 20, 2023
Nuwellis, Inc. Announces Fourth Quarter and Full Year 2022 Financial Results
February 27, 2023
Nuwellis, Inc. To Announce Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
February 6, 2023
Nuwellis Reports Preliminary Fourth Quarter and Full Year 2022 Revenue Results
January 8, 2023
Nuwellis Appoints Dr. John Jefferies as Chief Medical Officer
January 4, 2023
Nuwellis, Inc. Announces Passage of Warrant Proposal
January 3, 2023
Calls in 2023
Decks in 2023
- Investor Presentation (March 2023)
Investor deck · 26 slides · Mar 14, 2023